Acacia gum supplied as a veterinary-grade raw material for tablets, injections, capsules, powders, granules, premix, and solutions is a dried exudate obtained from Acacia senegal and, in certain commercial lots, Acacia seyal. The product carries CAS registry number 9000-01-5, EINECS number 232-519-5, and food-additive designation E414. The trade phrase “Veterinary Grade API” does not indicate a small-molecule receptor-active drug; it denotes a pharmacopoeial-grade raw material used as a tablet binder, emulsifier, suspending agent, capsule filler/binder, granulating aid, and solution-stabilizing hydrocolloid. The material is obtained by aqueous dissolution, mechanical filtration, and controlled drying, followed by spray-drying, granulation, or kibbling. The model designation is manufacturer-specific and should appear on the certificate of analysis along with the botanical source, processing route, and de-endotoxination status. No single universal model code exists, but the veterinary grade is distinguished from standard food-grade material by lower heavy-metal release limits, controlled microbial enumeration, and an endotoxin control option for injectable use. Compendial references include Ph. Eur. 0307, USP–NF Acacia, and JECFA specifications; food use in the United States is covered by 21 CFR 184.1330.

Compendial Acceptance Criteria and Grade Differentiation

Compendial specifications for acacia focus on identity, residue, ash, heavy metals, and microbiological quality. The table below lists representative release criteria referenced to the Ph. Eur. and USP–NF monographs. The exact acceptance limits must be verified against the current monograph edition and the regulatory submission for the target species. Spray-dried material has manufacturer-specific bulk density and particle size; these values are reported on the certificate of analysis for line setup and are not monograph requirements.

The acceptance criterion for bacterial endotoxins is not fixed in the acacia monograph; the manufacturer must derive the limit from the intended dose, route, and animal body weight according to Ph. Eur. 2.6.14 or USP 85. For oral powders and premixes, the endotoxin requirement is generally relaxed, but microbial enumeration remains critical because the gum is a polysaccharide and can support microbial growth when moist.

The functional behaviour of the gum in veterinary dosage forms is governed by the arabinogalactan-protein structure. The polysaccharide fraction is highly branched and contains galactose, arabinose, rhamnose, glucuronic acid, and 4-O-methylglucuronic acid; the proteinaceous component, typically 1–3 % of the dry mass, contributes interfacial activity. Weight-average molecular weight determined by size-exclusion chromatography with multi-angle laser light scattering is commonly reported between 2.4 × 10⁵ and 1.0 × 10⁶ Da. Aqueous solubility is high; a 25 % w/v solution can be prepared with gentle heat, whereas ethanol above approximately 50 % v/v precipitates the gum. The pH of a 10 % w/v aqueous solution is typically 4.0–4.6. Viscosity is lower than that of xanthan or guar at equivalent concentration; this makes acacia useful where a binder or emulsifier is required without a marked increase in vehicle viscosity. The material is not a gelling agent and does not form a heat-set gel.

In tablet formulations, acacia is generally used as a binder solution at 1–10 % w/v, added to achieve 1–5 % dry gum by tablet weight. In capsule operations, the low cold-water viscosity permits preparation of a 20–30 % w/v binder solution that can be metered without excessive nozzle blockage; the dried film contributes to granule strength but can retard disintegration if the binder is concentrated above the target range or if wet massing time is excessive. In powders and premixes, the spray-dried grade is dry-blended at 0.5–5.0 % w/w to improve homogeneity and reduce dusting. In oral solutions and suspensions, acacia gum is dispersed at 0.5–10 % w/v and acts as a protective colloid, reducing creaming and sedimentation.

How Does Moisture and Particle Geometry Affect High-Shear Granulation?

In high-shear wet granulation, spray-dried acacia with a low bulk density and fine particle size hydrates quickly and may form local gel lumps if the binder is added too rapidly. On production-scale high-shear mixers with impeller tip speed in the range 2–6 m/s and chopper speed 1,500–3,000 rpm, a 5 % w/v acacia solution is typically metered into the dry blend at a rate that keeps the power consumption curve below the over-wetting inflection. Wet massing time is usually limited to 1–5 min; beyond this, the gum may liberate bound water under shear, raise torque, and produce granules that collapse during drying. Granules are often wet-milled through a 1.0–1.5 mm screen and dried in a fluid-bed dryer at inlet air temperature 50–60 °C until loss on drying reaches 2–4 %. Published data for this specific veterinary-grade configuration is limited, so the endpoint must be defined by power draw, impeller torque, and dried granule sieve distribution rather than by fixed time alone. Residual moisture above 4 % increases the risk of caking in low-permeability packaging, while over-drying below 2 % may increase friability of the compressed tablet.

After drying, acacia-bound granules are sensitive to over-lubrication. Magnesium stearate at 0.5–1.0 % w/w can reduce tablet tensile strength if blended for more than 5 min. Compression is commonly run with pre-compression force 2–4 kN and main compression force 8–15 kN for 10 mm round tooling; tablet hardness is monitored at 60–100 N, and friability per USP 1216 or Ph. Eur. 2.9.7 is expected to remain below 0.8 %. Disintegration per USP 701 or Ph. Eur. 2.9.1 is often delayed beyond 15 min when acacia binder exceeds 5 % w/w; in such cases croscarmellose sodium at 2–4 % w/w or crospovidone at 2–5 % w/w is used to restore an acceptable disintegration window.

When Injectable Formulations Require Low-Endotoxin Acacia

Injectable use imposes controls that do not apply to feed premixes or oral powders. The gum must be de-endotoxinated by thermal, enzymatic, or membrane processing, and the certificate of analysis should report bacterial endotoxins by Limulus amebocyte lysate assay. The endotoxin limit is not fixed in the acacia monograph; it is calculated from the maximum intended dose volume, the animal body weight, and the route of administration using Ph. Eur. 2.6.14 or USP 85. For a parenteral product administered at 10 mL/kg, a common fluid limit is ≤ 0.5 EU/mL; the corresponding raw-material limit depends on the acacia concentration in the formula and must be derived case by case. The material must also meet particulate matter limits appropriate to the route, and the final solution must be filtered through a 0.22 µm or 0.45 µm membrane as required by the formulation. Acacia solutions for injection are often sterilized by filtration rather than autoclaving when high temperature promotes hydrolysis and pH drift. Any change from autoclaving to filtration must be supported by sterility assurance validation and visible-particle inspection according to Ph. Eur. 2.9.20. Acacia was historically used as a plasma volume expander; however, modern parenteral use is restricted to carefully validated formulations because of immunogenic protein residues and the possible deposition of high-molecular-weight fractions.

Acacia gum in solution is susceptible to microbial spoilage. Preserved systems should use a preservative with a wide pH range or store dry, and unpreserved solutions should not be held beyond 24 h at room temperature. The gum is incompatible with high concentrations of ethanol, tannins, ferric salts, and strongly oxidising agents; ferric salts may discolour the solution and form insoluble complexes. Coacervation with gelatin can occur at pH near the isoelectric point of the gelatin; this is used deliberately for encapsulation but is undesirable in simple solution formulations. In feed premixes, the powder is hygroscopic above 60 % RH; sacks should be stored below that relative humidity and re-sealed after use. When the gum is blended with water-soluble vitamins and trace minerals, the pH of the final premix should be controlled between 4.0 and 7.0 to avoid acid-catalysed depolymerisation. Published stability data for acacia in complex vitamin-mineral premixes is limited; a formulation-specific compatibility study is therefore required.

Processing Limits in Premix, Solution, Capsule, and Powder Operations

For dry powder and premix lines, spray-dried acacia is added early to the mixer to disperse and coat other particles. Ribbon blenders and double-cone blenders require periodic checks for static adhesion to vessel walls at relative humidity above 55 %. In capsule formulations, acacia powder can be used as a dry binder at 1–3 % w/w or as a granulating solution at 5–10 % w/v; hard gelatin capsules should be filled at ambient humidity not exceeding 60 % RH to avoid softening from residual moisture transferred from the acacia film. In solution manufacture, the gum should be added slowly to cold water under high-shear dispersion; if added all at once, fish-eye agglomerates form and require 60–90 min of gentle mixing to fully hydrate. For oral solutions, the final viscosity at 10 % w/v is low enough for peristaltic filling, but the filling nozzle diameter and line speed must be adjusted for the slightly increased tackiness of an acacia-containing vehicle. The powder is not suitable as a sole binder in dry granulation because its hygroscopicity can cause picking on the tablet press; it is preferably introduced as a wet binder or as a dry blend component below 5 % w/w.

Comparison Against Food-Grade Acacia and Competing Natural Gums

The veterinary grade differs from food-grade gum arabic chiefly in microbial enumeration, heavy-metal reporting, and the availability of an endotoxin-controlled lot. Food-grade acacia permitted under 21 CFR 184.1330 and E414 is not necessarily released against bacterial endotoxins or low heavy-metal limits suitable for parenteral use. Compared with gelatin, acacia does not gel on cooling and is not animal-derived; it therefore avoids thermal gelation in capsule and solution operations but lacks the elastic gel strength of gelatin in granule formation. Compared with xanthan gum, acacia is Newtonian at low concentration and produces lower solution yield stress, which is advantageous in metered liquid filling but provides less suspending power at equivalent concentration. Compared with guar gum, acacia hydrates without the same high-viscosity build and is less prone to over-thickening when concentration control is imperfect. Compared with pregelatinized starch, acacia produces a stronger granule at the same binder concentration but can prolong tablet disintegration more rapidly above 3 % w/w. The choice of acacia over these alternatives is therefore driven by its combination of cold-water solubility, low viscosity, interfacial activity, and acid-stable function in the pH range 4–7; it is not selected when high gel strength, high yield stress, or very low moisture sensitivity are the primary formulation requirements.